MedTrace Logo

A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens

NCT01416142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2013-12-25

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.

Conditions

  • Myopia

Interventions

DEVICE

PureVision2 HD contact lenses

Lenses to be worn through 1/2 of an HD movie. Following the movie, all subjects were to wear the dispensed contact lenses on a daily wear basis for approximately one week.

DEVICE

Spectacles

Spectacles to be worn throughout 1/2 of an HD movie.

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Bev Barna, CCRA · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-08-31
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416142 on ClinicalTrials.gov